Yahoo Finance Today's Research Reports on Cotinga Pharmaceuticals, Aurinia Pharmaceuticals, Resverlogix and Hamilton Thorne
NEW YORK, NY / ACCESSWIRE / January 15, 2019 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.
The Market Edge Initiates Coverage on:
Cotinga Pharmaceuticals Inc.
https://marketedgereport.com/report/COT.V/
Aurinia Pharmaceuticals Inc.
https://marketedgereport.com/report/AUP.TO/
Resverlogix Corp.
https://marketedgereport.com/report/RVX.TO/
Hamilton Thorne Ltd.
https://marketedgereport.com/report/HTL.V/
Cotinga Pharmaceuticals' stock jumped 9.09% Monday, to close the day at $0.06. The stock recorded a trading volume of 97,500 shares, which was above its three months average volume of 58,966 shares. In the last year, Cotinga Pharmaceuticals' shares have traded in a range of 0.05 - 1.05. The share price has gained 20% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.06 is lower than its 200-day moving average of $0.21.
Access The Market Edge's Cotinga Pharmaceuticals Inc. Research Report:
https://marketedgereport.com/report/COT.V/
On Monday, shares of Aurinia Pharmaceuticals recorded a trading volume of 98,909 shares, which was above the three months average volume of 56,603 shares. The stock ended the day 0.41% higher at $9.84. The share price has fallen 3.05% from its 52 week high with a 52 week trading range of 5.98 - 10.15. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $8.34 is greater than its 200-day moving average of $7.58. Shares of Aurinia Pharmaceuticals have gained approximately 6.15 percent year-to-date.
Access The Market Edge's Aurinia Pharmaceuticals Inc. Research Report:
https://marketedgereport.com/report/AUP.TO/
Resverlogix's stock moved 0.92% lower Monday, to close the day at $3.22. The stock recorded a trading volume of 18,580 shares, which was below its three months average volume of 42,630 shares. In the last year, Resverlogix's shares have traded in a range of 1.11 - 4.31. The share price has gained 190.09% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.17 is greater than its 200-day moving average of $3.12. Shares of Resverlogix have gained approximately 7.33 percent year-to-date.
Access The Market Edge's Resverlogix Corp. Research Report:
https://marketedgereport.com/report/RVX.TO/
On Monday, shares of Hamilton Thorne recorded a trading volume of 57,371 shares, which was below the three months average volume of 88,532 shares. The stock ended the day 3.7% lower at $1.04. The share price has fallen 18.75% from its 52 week high with a 52 week trading range of 0.71 - 1.28. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.93 is lower than its 200-day moving average of $1.01. Shares of the company are trading at a Price to Earnings ratio of 27.37. Shares of Hamilton Thorne have gained approximately 18.18 percent year-to-date.
Access The Market Edge's Hamilton Thorne Ltd. Research Report:
https://marketedgereport.com/report/HTL.V/
Our Actionable Research on Cotinga Pharmaceuticals Inc. (TSXV:COT.V), Aurinia Pharmaceuticals Inc. (TSX:AUP.TO), Resverlogix Corp. (TSX:RVX.TO) and Hamilton Thorne Ltd. (TSXV:HTL.V) can be downloaded free of charge at The Market Edge.
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Edge
